Although endothelins (ETs) were originally discovered as potent vasoconstrictors secreted by the endothelium (Yanagisawa et al., 1988), it has become evident that they also fulfill important roles in the nervous system (Schinelli, 2006). ETs are a family of 21-amino-acid peptides with three isoforms, ET-1, ET-2 and ET-3. ET-1 and ET-3 are present in most ocular structures. They are present in most regions of the anterior segment and in blood vessels of the choroid and the sclera (Chakrabarti and Sima, 1997). Precursor mRNAs of the three endothelins have been detected in the retina (Chakrabarti et al., 1998; Rattner and Nathans, 2005). ET-1 and ET-3 precursor mRNA appear in several retinal cell phenotypes (Ripodas et al., 2001), but the largest protein concentration appears in astrocytes (Torbidoni et al., 2005).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abbott, N. J., Ronnback, L., Hansson, E., 2006, Astrocyte-endothelial interactions at the blood-brain barrier, Nat. Rev. Neurosci. 7:41.
Blomstrand, F., Venance, L., Siren, A. L., Ezan, P., Hanse, E., Glowinski, J., Ehrenreich, H., Giaume, C., 2004, Endothelins regulate astrocyte gap junctions in rat hippocampal slices, Eur. J. Neurosci. 19:1005.
Chakrabarti, S., Gan, X. T., Merry, A., Karmazyn, M., Sima, A. A., 1998, Augmented retinal endothelin-1, endothelin-3, endothelinA and endothelinB gene expression in chronic diabetes, Curr. Eye Res. 17:301.
Chakrabarti, S., Sima, A. A., 1997, Endothelin-1 and endothelin-3-like immunoreactivity in the eyes of diabetic and non-diabetic BB/W rats, Diabetes Res. Clin. Pract. 37:109.
Chauhan, B. C., LeVatte, T. L., Jollimore, C. A., Yu, P. K., Reitsamer, H. A., Kelly, M. E., Yu, D. Y., Tremblay, F., Archibald, M. L., 2004, Model of endothelin-1-induced chronic optic neuropathy in rat, Invest. Ophthalmol. Vis. Sci. 45:144.
Clozel, M., Ramuz, H., Clozel, J. P., Breu, V., Hess, P., Loffler, B. M., Coassolo, P., Roux, S., 1999, Pharmacology of tezosentan, new endothelin receptor antagonist designed for parenteral use, J. Pharmacol. Exp. Ther. 290:840.
Davenport, A. P., Maguire, J. J., 2006, Endothelin, Handb. Exp. Pharmacol. 176 Pt 1:295.
de Raad, S., Szczesny, P. J., Munz, K., Reme, C. E., 1996, Light damage in the rat retina: glial fibrillary acidic protein accumulates in Muller cells in correlation with photoreceptor damage, Ophthalmic. Res. 28:99.
D’Orleans-Juste, P., Labonte, J., Bkaily, G., Choufani, S., Plante, M., Honore, J. C., 2002, Function of the endothelin(B) receptor in cardiovascular physiology and pathophysiology, Pharmacol. Ther. 95:221.
Drew, G. M., Coussens, C. M., Abraham, W. C., 1998, Effects of endothelin-1 on hippocampal synaptic plasticity, Neuroreport 9:1827.
Iandiev, I., Uhlmann, S., Pietsch, U. C., Biedermann, B., Reichenbach, A., Wiedemann, P., Bringmann, A., 2005, Endothelin receptors in the detached retina of the pig, Neurosci. Lett. 384:72.
Kis, B., Chen, L., Ueta, Y., Busija, D. W., 2006, Autocrine peptide mediators of cerebral endothelial cells and their role in the regulation of blood-brain barrier, Peptides 27:211.
MacCumber, M. W., Ross, C. A., Glaser, B. M., Snyder, S. H., 1989, Endothelin: visualization of mRNAs by in situ hybridization provides evidence for local action, Proc. Natl. Acad. Sci. U S A 86:7285.
Ostrow, L. W., Sachs, F., 2005, Mechanosensation and endothelin in astrocytes – hypothetical roles in CNS pathophysiology, Brain Res. Brain Res. Rev. 48:488.
Prasanna, G., Hulet, C., Desai, D., Krishnamoorthy, R. R., Narayan, S., Brun, A.-M., Suburo, A. M., Yorio, T., 2005, Effect of elevated intraocular pressure on endothelin-1 in a rat model of glaucoma, Pharmacol. Res. 51:41.
Rattner, A., Nathans, J., 2005, The genomic response to retinal disease and injury: evidence for endothelin signaling from photoreceptors to glia, J. Neurosci. 25:4540.
Ripodas, A., de Juan, J. A., Roldan-Pallares, M., Bernal, R., Moya, J., Chao, M., Lopez, A., Fernandez-Cruz, A., Fernandez-Durango, R., 2001, Localisation of endothelin-1 mRNA expression and immunoreactivity in the retina and optic nerve from human and porcine eye. Evidence for endothelin-1 expression in astrocytes, Brain Res. 912:137.
Schinelli, S., 2006, Pharmacology and physiopathology of the brain endothelin system: an overview, Curr. Med. Chem. 13:627.
Schinelli, S., Zanassi, P., Paolillo, M., Wang, H., Feliciello, A., Gallo, V., 2001, Stimulation of endothelin B receptors in astrocytes induces cAMP response element-binding protein phosphorylation and c-fos expression via multiple mitogen-activated protein kinase signaling pathways, J. Neurosci. 21:8842.
Siren, A. L., Lewczuk, P., Hasselblatt, M., Dembowski, C., Schilling, L., Ehrenreich, H., 2002, Endothelin B receptor deficiency augments neuronal damage upon exposure to hypoxia-ischemia in vivo, Brain Res. 945:144.
Sjostrand, F. S., 2003, Color vision at low light intensity, dark adaptation, Purkinje shift, critical flicker frequency and the deterioration of vision at low illumination. Neurophysiology at the nanometer range of neural structure, J. Submicrosc. Cytol. Pathol. 35:117.
Stokely, M. E., Brady, S. T., Yorio, T., 2002, Effects of endothelin-1 on components of anterograde axonal transport in optic nerve, Invest. Ophthalmol. Vis. Sci. 43:3223.
Torbidoni, V., Iribarne, M., Ogawa, L., Prasanna, G., Suburo, A. M., 2005, Endothelin-1 and its receptors in light-induced retinal degeneration, Exp. Eye Res. 81:265.
Torbidoni, V., Iribarne, M., Suburo, A. M., 2006, Endothelin receptors in light-induced retinal degeneration, Exp. Biol. Med. (Maywood) 231:1095.
Wassle, H., 2004, Parallel processing in the mammalian retina, Nat. Rev. Neurosci. 5:747.
Wu, K. H., Madigan, M. C., Billson, F. A., Penfold, P. L., 2003, Differential expression of GFAP in early v late AMD: a quantitative analysis, Br. J. Ophthalmol. 87:1159.
Yagami, T., Ueda, K., Sakaeda, T., Okamura, N., Nakazato, H., Kuroda, T., Hata, S., Sakaguchi, G., Itoh, N., Hashimoto, Y., Fujimoto, M., 2005, Effects of an endothelin B receptor agonist on secretory phospholipase A2-IIA-induced apoptosis in cortical neurons, Neuropharmacology 48:291.
Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K., Masaki, T., 1988, A novel potent vasoconstrictor peptide produced by vascular endothelial cells, Nature 332:411.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Torbidoni, V., Iribarne, M., Suburo, A.M. (2008). Endothelin Receptors: Do They Have a Role in Retinal Degeneration?. In: Anderson, R.E., LaVail, M.M., Hollyfield, J.G. (eds) Recent Advances in Retinal Degeneration. Advances in Experimental Medicine and Biology, vol 613. Springer, New York, NY. https://doi.org/10.1007/978-0-387-74904-4_47
Download citation
DOI: https://doi.org/10.1007/978-0-387-74904-4_47
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-74902-0
Online ISBN: 978-0-387-74904-4
eBook Packages: MedicineMedicine (R0)